These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. An audience with... Arti Rai. Rai A Nat Rev Drug Discov; 2007 Apr; 6(4):264. PubMed ID: 17457998 [No Abstract] [Full Text] [Related]
24. Patenting nanotechnology. Lemley MA Stanford Law Rev; 2005 Nov; 58(2):601-30. PubMed ID: 16395838 [TBL] [Abstract][Full Text] [Related]
25. The gene patenting controversy: a convergence of law, economic interests, and ethics. Kevles DJ; Berkowitz A Brooklyn Law Rev; 2001; 67(1):233-48. PubMed ID: 12645549 [No Abstract] [Full Text] [Related]
26. Intellectual property. Decision on NFkappaB patent could have broad implications for biotech. Garber K Science; 2006 May; 312(5775):827. PubMed ID: 16690824 [No Abstract] [Full Text] [Related]
30. Beyond the letter of the law: the US Federal Circuit interprets section 271(g)(1). Tsao R; Hurley EA Nat Biotechnol; 1997 Jan; 15(1):86-7. PubMed ID: 9035112 [No Abstract] [Full Text] [Related]
35. Biotech as Bush bows out. Lorenzo A Nat Biotechnol; 2008 Jan; 26(1):15-8. PubMed ID: 18183006 [No Abstract] [Full Text] [Related]
36. Intellectual property protection for plant-related inventions in Europe. Fleck B; Baldock C Nat Rev Genet; 2003 Oct; 4(10):834-8. PubMed ID: 14526379 [TBL] [Abstract][Full Text] [Related]
37. The patentability of antibodies in the United States. Lu DL; Collison AM; Kowalski TJ Nat Biotechnol; 2005 Sep; 23(9):1079-80. PubMed ID: 16151395 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic testing of genetic disorders: limiting the scope of patent claims through disclosure requirements. Abbot J J Law Med; 2006 Aug; 14(1):110-26. PubMed ID: 16937785 [TBL] [Abstract][Full Text] [Related]